Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: A multicenter randomized controlled trial

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 8, 2000, Pages 2028-2033

  Dupont, H ^a   Carbon, C ^a   Carlet, J ^b  

^a BICHAT HOSPITAL   (France)

^b SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; PIPERACILLIN PLUS TAZOBACTAM;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANAEROBIC BACTERIUM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; PERITONITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ADOLESCENT; ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLANIC ACID; PENICILLINS; PERITONITIS; PIPERACILLIN; TREATMENT OUTCOME;

EID: 0033915639     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.8.2028-2033.2000     Document Type: Article

References (32)

1. Barie, P. S., S. B. Vogel, P. Dellinger, O. D. Rotstein, J. S. Solomkin, J. Y. Yang, and J. F. Baumgartner. 1997. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Arch. Surg. 132:1294-1302.
2. Berger, R. L., and C. H. Jason. 1996. Bioequivalence trial, intersection-union tests and equivalence confidence sets. Stat. Sci. 11:283-319.
3. Bone, R. C., C. J. Grodzin, and R. A. Balk. 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235-243.
4. Brismar, B., A. S. Malmborg, G. Tunevall, B. Wretlind, L. Bergman, L. O. Mentzing, P. O. Nyström, E. Kihlström, B. Bäckstrand, T. Skau, B. Kasholm-Tengve, L. Sjöberg, B. Olsson-Liljequist, F. P. Tally, L. Gatenbeck, A. E. Eklund, and C. E. Nord. 1992. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Antimicrob. Agents Chemother. 36:2766-2773.
5. Burnett, R. J., D. C. Haverstock, E. P. Dellinger, H. H. Reinhart, J. M. Bohnen, O. D. Rotslein, S. B. Vogel, and J. S. Solomkin. 1995. Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 118:716-721.
6. Calandra, T., and A. Cometta. 1991. Antibiotic therapy for gram-negative bacteremia. Infect. Dis. Clin. N. Am. 5:817-834.
7. Colardyn, F., and K. L. Faulkner. 1996. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group. J. Antimicrob. Chemother. 38:523-537.
8. Cometta, A., and J. D. Baumgartner. 1996. Treatment of severe infections: should one always administer an aminoglycoside? Schweiz Med. Wochenschr. Suppl. 76:28S-33S.
9. Cometta, A., J. D. Baumgartner, D. Lew, W. Zimmerli, D. Pittet, P. Chopart, U. Schaad, C., Herter, P. Eggimann, O. Huber, B. Ricou, P. Suter, R. Auckenthaler, R. Chiorelo, J. Bille, C. Scheidegger, R. Frei, and M. P. Glauser. 1994. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob. Agents Chemother. 38:1309-1313.
10. Comité de l'Antibiogramme de la Société Française de Microbiologie. 1996. Communiqué 1996. Pathol. Biol. 44:1-8.
11. Deheuvels, P. 1984. How to analyse bioequivalence studies? The right use of confidence intervals. J. Organ. Behav. Stat. 1:1-15.
12. Falagas, M. E., L. Barefoot, J. Griffith, K. Ruthazar, and D. R. Snydman. 1996. Risk factors leading to clinical failure in the treatment of intraabdominal or skin/soft tissue infections. Eur. J. Clin. Microbiol. Infect. Dis. 15:913-921.
13. Fantin, B., and C. Carbon. 1990. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. Antimicrob. Agents Chemother. 34:2387-2391.
14. Gorbach, S. L. 1993. Treatment of intra-abdominal infections. J. Antimicrob. Chemother. 31(Suppl. A):67-78.
15. Ho, J. L., and M. Barza. 1987. Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection. Antimicrob. Agents Chemother. 31: 485-491.
16. Isaksson, B., L. Nilsson, R. Maller, and L. Sören. 1988. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method. J. Antimicrob. Chemother. 22:23-33.
17. Johnson, C. C., J. Baldessare, and M. E. Levison. 1997. Peritonitis: update on pathophysiology, clinical manifestations, and management. Clin. Infect. Dis. 24:1035-1047.
18. Le Gall, J. R., S. Lemeshow, and F. Saulnier. 1943. A new simplified acute physiology score (SAPS II) based on a European-North American multicenter study. JAMA 270:29057-29068.
19. MacCabe, W. R., and G. G. Jackson. 1962. Gram negative bacteremia, etiology and ecology. Arch. Intern. Med. 110:845.
20. McGregor, R. R. 1977. Comparative penetration of amikacin, gentamicin, and penicillin G into exudate fluid in experimental sterile peritonitis. Antimicrob. Agents Chemother. 11:110-113.
21. Moellering, R. C. 1983. In vitro antibacterial activity of the aminoglycoside antibiotics. Rev. Infect. Dis. 5:S212-S232.
22. Montravers, P., R. Gauzit, C. Muller, J. P. Marmuse, A. Fichelle, and J. M. Desmonts. 1996. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin. Infect. Dis. 23:486-494.
23. Montravers, P., J. Mohler, L. Maulin, and C. Carbon. 1998. Early bacterial and inflammatory responses to antibiotic therapy in a model of polymicrobial peritonitis in rats. Clin. Microbiol. Infect. 4:701-705.
24. Mosdell, D. M., D. M. Morris, A. Voltura, D. E. Pitcher, M. W. Twiest, R. L. Milne, B. G. Miscall, and D. E. Fry. 1991. Antibiotic treatment for surgical peritonitis. Ann. Surg. 214:543-549.
25. Pacelli, F., G. Battista Doglietto, S. Alfieri, E. Piccioni, A. Sgadari, and E. Crucciti. 1996. Prognosis of intra-abdominal infections. Arch. Surg. 131:641-645.
26. Rybak, M. J., and B. J. McGrath. 1996. Combination antimicrobial therapy for bacterial infections. Drugs 52:390-405.
27. Sawyer, R. G., L. K. Rosenlof, R. B. Adams, A. K. May, M. D. Spengler, and T. L. Pruett. 1992. Peritonitis into the 1990's: changing pathogens and changing strategies in the critically ill. Am. Surg. 58:82-87.
28. Sawyer, R. G., M. D. Spengler, R. B. Adams, and T. L. Pruett. 1991. The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH. Ann. Surg. 213:253-260.
29. Solomkin, J. S., E. P. Dellinger, N. V. Christou, and R. W. Busuttil. 1990. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann. Surg. 212:581-591.
30. Solomkin, J. S., D. L. Hemsell, R. Sweet, F. Tally, and J. Barret. 1992. Evaluation of new anti-infective drugs for the treatment of intra-abdominal infections. Clin. Infect. Dis. 15:S33-S42.
31. Solomkin, J. S., J. L. Meakins, M. D. Allo, E. P. Dellinger, and R. L. Simmons. 1984. Antibiotic trials in intra-abdominal infections. Ann. Surg. 200:29-39.
32. Wilson, W. R., A. W. Karchmer, A. S. Dajani, K. A. Taubert, A. Bayer, D. Kaye, A. L. Bisno, P. Ferrieri, S. T. Shulman, and D. T. Durack. 1995. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 274:1706-1713.